|
Idiopathic
|
1
|
Minimal change
|
1
|
Minimal lesion pattern
|
mes and subendo
|
normal urinalysis (donor kidney at 0 hour biopsy)
|
#26
|
2
| |
NA
|
NS
|
#25
|
1
| |
mes
|
NS
|
#27
|
2
|
Mesangial proliferative GN
|
1
|
Mesangial proliferative pattern
|
NA
|
SubNS, hematuria
|
#25
|
1
| |
NA
|
NS and nephritic
|
#28
|
1
| |
mes
|
SubNS
|
#24
|
3
|
Focal proliferative GN
|
5
|
Focal proliferative pattern
|
2 subepi; 1 TM and subepi; 2 NA
|
NS; or NS and hematuria
|
#25
|
2
| |
mes, subendo, subepi
|
NS
|
#23
|
4
|
Diffuse proliferative GN
|
2
|
Diffuse proliferative pattern
|
NA
|
RPGN, NS, malignant HTN
|
#25
|
1
| |
NA
|
SubNS, hypertension
|
#29
|
7
| |
NA
|
NS; or subNS; or NS and nephritic; or RPGN
|
#28
|
10
| |
NA
|
NS; or nephritic; or NS and nephritic; or CRF
|
#30
|
7
| |
mes, subendo, subepi
|
NS or subNS, hematuria, renal insufficiency
|
#23
|
5
|
Diffuse proliferative GN with crescents
|
2
|
Diffuse proliferative with crescents
|
mes, subendo, subepi; subepi
|
RPGN, subNS, hematuria, malignant HTN
|
#25
|
10
| |
NA
|
NA
|
#30
|
2
| |
mes, subendo, subepi
|
SubNS and hematuria
|
#22
|
1
| |
mes, subendo, subepi
|
SubNS, hematuria and renal insufficiency
|
#23
|
6
|
MPGN
|
1
|
Membranoproliferative pattern
|
mes, subendo, subepi
|
NS
|
#25
|
2
| |
NA
|
NS and nephritic
|
#28
|
3
| |
mes and subendo
|
RPGN; chronic renal failure;or NS
|
#24
|
1
| |
NA
|
NS and nephritic
|
#29
|
12
| |
NA
|
RPGN; or NS; or NS and nephritic
|
#30
|
1
| |
mes, subendo, subepi
|
NS, hemturia
|
#22
|
3
| |
mes, subendo, subepi
|
NS, hematuria
|
#23
|
7
|
MN
|
1
|
Membranous pattern
|
NA
|
NS, renal insufficiency
|
#29
|
2
| |
NA
|
1 NS; 1 NS and nephritic
|
#28
|
10
| |
subepi
|
NS; or subNS
|
#24
|
21
| |
NA
|
NS; or subNS with nephritic
|
#30
|
4
| |
mes, subendo, subepi
|
NS or subNS
|
#23
|
8
|
Diffuse proliferative GN with MN
|
1
|
Diffuse proliferative and membranous patterns
|
mes, subendo, subepi
|
NS, hematuria, renal insufficiency
|
#22
|
9
|
FSGS
|
2
|
Segmental chronic lesions
|
1 mes, subendo, subepi; 1 NA
|
NS
|
#25
|
10
|
FSGS with TMA
|
1
|
Segmental chronic lesions and TMA
|
NA
|
NS
|
#25
|
11
|
C1q nephropathy
|
1
|
Diffuse proliferative pattern
|
mes and subendo
|
NS
|
#24
|
3
|
Proliferative GN in 1; minima change in 2
|
NA
|
NA
|
#30
|
12
|
IgA nephropathy
|
1
|
Segmental chronic lesions
|
NA
|
SubNS and hematuria
|
#25
|
3
|
Focal mesangial proliferative pattern
|
mes
|
NS; SubNS; or chronic renal failure
|
#24
|
16
|
Mesangial proliferative pattern
|
NA
|
NA
|
#30
|
13
|
IgA nephropathy with crescents
|
3
|
Focal or diffuse proliferative pattern with crescents
|
1 subendo; 2 NA
|
SubNS, hematuria, RPGN, malignant HTN
|
#25
|
2
|
Focal or diffuse proliferative pattern with crescents
|
mes
|
RPGN
|
#24
|
|
Secondary
|
14
|
Infection-related GN
|
1
|
Minimal lesion pattern
|
mes and subendo
|
Microalbuminemia, hematuria
|
#25
|
1
|
Diffuse proliferative pattern
|
mes, subendo, TM, subepi humps
|
RPGN
|
#25
|
15
|
Infecious endocarditis-related GN
|
1
|
Diffuse proliferative pattern
|
subepithelial humps
|
MSSA infectious endocarditis
|
#24
|
16
|
Post-streptocococal GN
|
2
|
Diffuse proliferative pattern
|
subepithelial humps
|
Nephritic; or NS
|
#24
|
17
|
IgA-dominant infection-related GN
|
2
|
Diffuse mesangial proliferative pattern
|
NA
|
NA
|
#30
|
1
|
Diffuse proliferative pattern
|
subepithelial humps
|
Nephritic
|
#24
|
18
|
HBV-associated MN
|
1
|
Membranous pattern
|
subepi
|
NS
|
#24
|
1
|
Membranous pattern
|
NA
|
NS
|
#30
|
19
|
HIV-associated immune complex GN (6 cases with concurrent HCV infection)
|
6
|
Focal proliferative pattern
|
mes, subendo, subepi
|
NS or subNS, hematuria, renal insufficiency, 1 HCV+
|
#31
|
7
|
Diffuse proliferative pattern
|
mes, subendo, subepi
|
NS or subNS, hematuria, renal insufficiency, 4 HCV+
|
#31
|
1
|
Membranous pattern
|
subepi, TM, subendo, mes
|
NS, HCV+
|
#31
|
20
|
ANCA-associated GN
|
2
|
Diffuse proliferative pattern with crescents
|
NA
|
RPGN; or subNS and hematuria
|
#25
|
1
|
Membranoproliferative pattern with crescents
|
NA
|
RPGN, HTN crisis, p-ANCA positive
|
#32
|
21
|
Amyloidosis
|
7
|
Amyloid protein deposition
|
NA
|
NA
|
#30
|
22
|
Cancer-associated MN
|
3
|
Membranous, anti-PLA2R negative
|
1 mes, subepi; 2 subepi
|
NS; or subNS and hematuria; all with cancer
|
#25
|
23
|
Glomerular disease in IPEX patient
|
1
|
Membranous with focal proliferative pattern
|
mes, subendo, subepi
|
NS, hematuria
|
#33
|